Xiaoyun Ding

Dr. Xiaoyun Ding


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2013 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
HSHaojun Song
Haojun Song
WSWeiliang Sun
Weiliang Sun
GYGuoliang Ye
Guoliang Ye
XDXiaoyun Ding
Xiaoyun Ding
ZLZhong Liu
Zhong Liu
JGJunming Guo
Junming Guo
Background: Long non-coding RNAs (lncRNAs) are prevalently transcribed in the genome yet their potential roles in human cancers are not well understood. The aim of the present study was to determine the lncRNA expression profile in gastric cancer and its potential clinical value. Methods: The global lncRNA expression profile in gastric cancer was measured by lncRNA microarray. Levels of two representative lncRNAs, H19 and uc001lsz, were confirmed by real-time reverse transcriptase-polymerase chain reaction. The relationship between their levels and clinicopathological factors of patients with gastric cancer was explored. A receiver operating characteristic (ROC) curve was constructed for differentiating gastric cancer from benign gastric diseases. Results: Total of 135 lncRNAs, which differential expression levels between tumor and non-tumorous tissues were more than twofold, were found (GEO No. GSE47850). The most down-regulated lncRNAs in gastric cancer tissues were FER1L4, uc001lsz, BG491697, AF131784, uc009ycs, BG981369, AF147447, HMlincRNA1600, and AK054588; while the most up-regulated ones were H19, HMlincRNA717, BM709340, BQ213083, AK054978, and DB077273. H19 was found highly expressed in stomach and liver cancer cell lines, while lowly expressed in lung cancer and prostate cancer cell lines. Uc001lsz was lowly expressed in gastric, lung and liver cancer cell lines, while highly expressed in prostate cancer. The areas under ROC curves were up to 0.613, 0.751, and 0.761 for H19, uc001lsz, and the combination, respectively. Conclusions: The lncRNA expression profile in gastric cancer suggests the potential roles of lncRNAs in gastric cancer occurrence and development. The overexpression of H19 in gastric cancer suggests that H19 may be participated in gastric cancer. The reduced expression of uc001lsz in gastric cancer cell lines and tissues, its associations with TNM stage, and its dysregulation in early cancer and precancerous lesions suggest that uc001lsz may be a potential marker for the diagnosis of early gastric cancer.

1 July 2014 in Cancer
Verified
Journal Article
Open access
PDF file
YSYongfu Shao
Yongfu Shao
MYMeng Ye
Meng Ye
XJXiaoming Jiang
Xiaoming Jiang
WSWeiliang Sun
Weiliang Sun
XDXiaoyun Ding
Xiaoyun Ding
JGJunming Guo
Junming Guo
BACKGROUND: Long noncoding RNAs (lncRNAs) play a crucial role in tumorigenesis. However, the value of lncRNAs in the diagnosis of gastric cancer remains unknown. To identify whether lncRNA‐AA174084 is a potential marker for the early diagnosis of gastric cancer (GC), the authors investigated its levels in tissues, blood, and gastric juices from patients with various stage of gastric tumorigenesis.METHODS: Total RNA in 860 specimens from patients and healthy controls was extracted. Levels of AA174084 in 134 paired GC tissues, 127 gastric mucosal tissues, 335 plasma samples, and 130 gastric juice samples at each stage of gastric tumorigenesis were measured using real‐time reverse transcriptase‐polymerase chain reaction analysis. The potential association between AA174084 levels and patients' clinicopathologic features were analyzed. A receiver operating characteristic (ROC) curve was constructed for differentiating GC patients from controls.RESULTS: Expression levels of AA174084 were down‐regulated significantly in 95 of 134 GC tissues (71%) compared with the levels in paired, adjacent, normal tissues (P < .001). AA174084 levels had significant, negative correlations with age (P = .031), Borrmann type (P = .016), and perineural invasion (P = .032). Plasma AA174084 levels in patients with GC dropped markedly on day 15 after surgery compared with preoperative levels (P < .001) and were associated with invasion (P = .049) and lymphatic metastasis (P = .042). AA174084 levels in gastric juice from patients with GC were significantly higher than the levels in normal mucosa or in patients with minimal gastritis, gastric ulcers, and atrophic gastritis (P < .001). The area under ROC was up to 0.848 (P < .001).CONCLUSIONS: AA174084 may have potential as marker for the early diagnosis of GC. Cancer 2014;120:3320–3328. © 2014 American Cancer Society.

1 September 2013 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
DMDanyi Mei
Danyi Mei
HSHaojun Song
Haojun Song
KWKai Wang
Kai Wang
YLYichao Lou
Yichao Lou
WSWeiliang Sun
Weiliang Sun
JGJunming Guo
Junming Guo

31 August 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LXLei Xu
Lei Xu
CXChengfu Xu
Chengfu Xu
CYChaohui Yu
Chaohui Yu
MMMin Miao
Min Miao
XZXuequn Zhang
Xuequn Zhang
YLYouming Li
Youming Li
Growth hormone (GH) is an important regulator of metabolism and body composition. GH deficiency is associated with increased visceral body fat and other features of the metabolic syndrome. Here we performed a cross-sectional study to explore the association of GH levels with nonalcoholic fatty liver disease (NAFLD), which is considered to be the hepatic manifestation of the metabolic syndrome. A total of 1,667 subjects were diagnosed as NAFLD according the diagnostic criteria, and 5,479 subjects were defined as the controls. The subjects with NAFLD had significantly lower levels of serum GH than the controls. Those with low GH levels had a higher prevalence of NAFLD and the metabolic syndrome. A stepwise logistic regression analysis showed that GH levels were significantly associated with the risk factor for NAFLD (OR = 0.651, 95%CI = 0.574–0.738, P<0.001). Our results showed a significant association between lower serum GH levels and NAFLD.

1 February 2015 in Tumor Biology
Verified
Journal Article
Open access
PDF file
XWXiangxiang Wan
Xiangxiang Wan
XDXiaoyun Ding
Xiaoyun Ding
SCShengcan Chen
Shengcan Chen
HSHaojun Song
Haojun Song
HJHaizhong Jiang
Haizhong Jiang
JGJunming Guo
Junming Guo
Gastric cancer is one of the most common malignant diseases and has one of the highest mortality rates worldwide. Its molecular mechanisms are poorly understood. Recently, the functions of non-coding RNAs (ncRNAs) in gastric cancer have attracted wide attention. Although the expression levels of various ncRNAs are different, they may work together in a network and contribute to gastric carcinogenesis by altering the expression of oncogenes or tumor suppressor genes. They affect the cell cycle, apoptosis, motility, invasion, and metastasis. Dysregulated microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), including miR-21, miR-106, H19, and ANRIL, directly or indirectly regulate carcinogenic factors or signaling pathways such as PTEN, CDK, caspase, E-cadherin, Akt, and P53. Greater recognition of the roles of miRNAs and lncRNAs in gastric carcinogenesis can provide new insight into the mechanisms of tumor development and identify targets for anticancer drug development.

7 September 2018 in World Journal of Gastroenterology
Verified
Journal Article
Open access
MLMeng-Ting Lin
Meng-Ting Lin
HSHao-Jun Song
Hao-Jun Song
XDXiaoyun Ding
Xiaoyun Ding
Long non-coding RNAs involved in metastasis of gastric cancer